Delivery Order SPE2DR25D9112-SPE2DR26FDEK4
Award Date 11/10/25
Potential Completion Date 11/12/25
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units) valued at $24,676.82. The delivery order, awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a $12,364.81 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. on August 4, 2025, for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This award utilizes a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete directly in the...
- The Defense Logistics Agency issued a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc. for 60 tablets of JAKAFI 20 mg on October 27, 2025, with an ultimate completion date of October 28, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, indicating the award was made through unrestricted federal procurement competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 2, 2025, for the supply of Jakafi 5 mg tablets (60 count) with a contract value of $24,293.60. This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, represents a fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through November 2026. The award was made without a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,400.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packages). This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a $24,293.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on October 21, 2025, for the supply of Jakafi (ruxolitinib) 5 mg tablets in quantities of 60 units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, was awarded without set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,999.80 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 15 mg tablets (60-count units). This contract is not set-aside designated and carries a firm fixed-price structure with an ultimate completion date of September 3, 2025. The delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 5 mg on June 17, 2025. This firm fixed-price delivery order, with an ultimate completion date of June 18, 2025, is being fulfilled from Park Ridge, Illinois. The award utilizes no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical procurement...